NEW YORK, NY / ACCESSWIRE / September 13, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
TUFN Shareholders Click Here: https://www.zlk.com/pslra-1/tufin-software-technologies-ltd-loss-form?prid=9225&wire=1
VXRT Shareholders Click Here: https://www.zlk.com/pslra-1/vaxart-inc-information-request-form-2?prid=9225&wire=1
FENC Shareholders Click Here: https://www.zlk.com/pslra-1/fennec-pharmaceuticals-inc-information-request-form?prid=9225&wire=1
* ADDITIONAL INFORMATION BELOW *
Tufin Software Technologies Ltd. (NYSE:TUFN)
Affected investors purchased TUFN securities pursuant and/or traceable to documents issued in connection with the Company's April 2019 initial public offering and/or its December 2019 secondary public offering.
Lead Plaintiff Deadline : September 21, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/tufin-software-technologies-ltd-loss-form?prid=9225&wire=1
According to the filed complaint, (i) Tufin's customer relationships and growth metrics were overstated, particularly with respect to North America; (ii) Tufin's business was deteriorating, primarily in North America; (iii) as a result, Tufin's representations regarding its sustainable financial prospects were overly optimistic; and (iv) as a result, the documents issued in connection with the Company's initial public offering were materially false and/or misleading and failed to state information required to be stated therein.
Vaxart, Inc. (NASDAQ:VXRT)
VXRT Lawsuit on behalf of: investors who purchased June 25, 2020 - July 25, 2020
Lead Plaintiff Deadline : October 23, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/vaxart-inc-information-request-form-2?prid=9225&wire=1
According to the filed complaint, during the class period, Vaxart, Inc. made materially false and/or misleading statements and/or failed to disclose that: 1) Vaxart exaggerated the prospects of its COVID-19 vaccine candidate, including its purported role or involvement in Operation Warp Speed ('OWS'), a program which commits the federal government to massive funding for the development of COVID-19 vaccines; 2) Vaxart's COVID-19 vaccine candidate had no reasonable prospect for mass production and marketing and was not among the companies chosen to receive significant financial support from OWS to produce hundreds of millions of vaccine doses; and 3) Vaxart's COVID-19 vaccine candidate was merely selected to participate in preliminary U.S. government studies to determine potential areas for possible OWS partnership and support.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC)
FENC Lawsuit on behalf of: investors who purchased February 11, 2020 - August 10, 2020
Lead Plaintiff Deadline : November 2, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/fennec-pharmaceuticals-inc-information-request-form?prid=9225&wire=1
According to the filed complaint, during the class period, Fennec Pharmaceuticals Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the manufacturing facilities for PEDMARK, the Company's sole product candidate, did not comply with current good manufacturing practices; (2) as a result, regulatory approval for PEDMARK was reasonably likely to be delayed; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
https://www.zlk.com
SOURCE: Levi & Korsinsky, LLP